The Largest US Civilian Ammo Producer Just Sold ALL Of Their Factories! Here’s Why You Should Worry!March 10, 2026
Liam Williams on March 10, 2026 8:00 am I like the balance sheet here—less leverage than peers. Reply
Liam U. Garcia on March 10, 2026 8:00 am Silver leverage is strong here; beta cuts both ways though. Reply
Oliver Smith on March 10, 2026 8:01 am Silver leverage is strong here; beta cuts both ways though. Reply
James Y. Martinez on March 10, 2026 8:03 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Isabella Moore on March 10, 2026 8:03 am Nice to see insider buying—usually a good signal in this space. Reply
Olivia Hernandez on March 10, 2026 8:03 am Nice to see insider buying—usually a good signal in this space. Reply
Isabella N. Martinez on March 10, 2026 8:05 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Emma Rodriguez on March 10, 2026 8:05 am Interesting update on Iran Sleeper Cells ACTIVATING – New Dictator WOUNDED. Curious how the grades will trend next quarter. Reply
Patricia Smith on March 10, 2026 8:07 am If AISC keeps dropping, this becomes investable for me. Reply
Patricia Williams on March 10, 2026 8:07 am If AISC keeps dropping, this becomes investable for me. Reply
Elijah Martinez on March 10, 2026 8:08 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
John Lopez on March 10, 2026 8:08 am Interesting update on Iran Sleeper Cells ACTIVATING – New Dictator WOUNDED. Curious how the grades will trend next quarter. Reply
Ava A. Williams on March 10, 2026 8:13 am Silver leverage is strong here; beta cuts both ways though. Reply
Elijah Martin on March 10, 2026 8:13 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
35 Comments
I like the balance sheet here—less leverage than peers.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Interesting update on Iran Sleeper Cells ACTIVATING – New Dictator WOUNDED. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Interesting update on Iran Sleeper Cells ACTIVATING – New Dictator WOUNDED. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
The cost guidance is better than expected. If they deliver, the stock could rerate.